Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Karn

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Breast Cancer Research and Treatment|January 5, 2011
Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistanceThomas Karn, Eugen Ruckhäberle, Lars Hanker, et al.
Breast Cancer Research and Treatment|May 21, 2009
Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancerThomas Karn, Dirk Metzler, Eugen Ruckhäberle, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2008
Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysisAchim Rody, Thomas Karn, Eugen Ruckhäberle, et al.
Scientific Reports|October 19, 2019
Identification and Validation of a Novel Biologics Target in Triple Negative Breast CancerVikram B Wali, Gauri A Patwardhan, Vasiliki Pelekanou, et al.
British Journal of Cancer|November 7, 2023
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapyLuca Licata, Marco Barreca, Barbara Galbardi, et al.
Breast Cancer Research and Treatment|December 7, 2007
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancerEugen Ruckhäberle, Achim Rody, Knut Engels, et al.
Oncotargets and Therapy|December 16, 2014
Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancerIsabell Witzel, Karin Milde-Langosch, Marcus Schmidt, et al.
Breast Cancer Research and Treatment|July 22, 2015
The prognostic impact of age in different molecular subtypes of breast cancerCornelia Liedtke, Achim Rody, Oleg Gluz, et al.
Breast Cancer Research and Treatment|April 17, 2014
Prognostic relevance of glycosylation-associated genes in breast cancerKarin Milde-Langosch, Thomas Karn, Marcus Schmidt, et al.
NPJ Breast Cancer|November 7, 2022
Molecular differences between younger versus older ER-positive and HER2-negative breast cancersTao Qing, Thomas Karn, Mariya Rozenblit, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Breast Cancer Research and Treatment|January 5, 2011
Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistanceThomas Karn, Eugen Ruckhäberle, Lars Hanker, et al.
Breast Cancer Research and Treatment|May 21, 2009
Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancerThomas Karn, Dirk Metzler, Eugen Ruckhäberle, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2008
Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysisAchim Rody, Thomas Karn, Eugen Ruckhäberle, et al.
Scientific Reports|October 19, 2019
Identification and Validation of a Novel Biologics Target in Triple Negative Breast CancerVikram B Wali, Gauri A Patwardhan, Vasiliki Pelekanou, et al.
British Journal of Cancer|November 7, 2023
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapyLuca Licata, Marco Barreca, Barbara Galbardi, et al.
Breast Cancer Research and Treatment|December 7, 2007
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancerEugen Ruckhäberle, Achim Rody, Knut Engels, et al.
Oncotargets and Therapy|December 16, 2014
Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancerIsabell Witzel, Karin Milde-Langosch, Marcus Schmidt, et al.
Breast Cancer Research and Treatment|July 22, 2015
The prognostic impact of age in different molecular subtypes of breast cancerCornelia Liedtke, Achim Rody, Oleg Gluz, et al.
Breast Cancer Research and Treatment|April 17, 2014
Prognostic relevance of glycosylation-associated genes in breast cancerKarin Milde-Langosch, Thomas Karn, Marcus Schmidt, et al.
NPJ Breast Cancer|November 7, 2022
Molecular differences between younger versus older ER-positive and HER2-negative breast cancersTao Qing, Thomas Karn, Mariya Rozenblit, et al.
Pageof 11